Français
4. Benefit/risk balance of nanoparticle-based drugs
4.1 Concept of benefit/risk balance
As mentioned in the 2 section of this article, a drug can be formulated in a nanoparticle (encapsulation) or be the nanoparticle itself. For example, the aim is to:
improve or control bioavailability
The Ultimate Scientific and Technical Reference
A Comprehensive Knowledge Base, with over 1,200 authors and 100 scientific advisors
+ More than 10,000 articles and 1,000 how-to sheets, over 800 new or updated articles every year
From design to prototyping, right through to industrialization, the reference for securing the development of your industrial projects
This article is included in
Drugs and pharmaceuticals
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Ongoing reading
Benefit/risk balance of nanoparticle-based drugs
Benefit/risk balance of nanoparticle-based drugs
Conclusion
Bibliography
Standards and norms
- Nanotechnologies, guidance on physicochemical characterization of engineered nanoscale materials for toxicological assessment. - ISO/TR-13014 :2012 - 2012
- Nanotechnologies – Measurements Technique Matrix for the Characterization of Nano-Objects. ISO. - ISO/TR-18196 :2016 - 2016
- Nanotechnologies – Terminology and definitions for nano-objects, nanoparticle, nanofibre and nanoplate. - ISO/TS - 2008
- Particle...
The Ultimate Scientific and Technical Reference
A Comprehensive Knowledge Base, with over 1,200 authors and 100 scientific advisors
+ More than 10,000 articles and 1,000 how-to sheets, over 800 new or updated articles every year
From design to prototyping, right through to industrialization, the reference for securing the development of your industrial projects
